Vials and ampoules

In the pharmaceutical industry, products must be identifiable from their point of origin through purchase by the end consumer, following the various international regulations established in this regard, such as the European Directive 2011/62/EU and the Drug Supply Chain and Security Act (DSCSA) in the US. Other countries have also announced similar requirements, including India, China (SFDA DMF), Argentina, Brazil (Anvisa RDC-54), Turkey, and others.


All the directives and laws enacted around the world share the objective of guaranteeing safety and preventing the sale of counterfeit medicines that pose a threat to public health. To ensure proper identification and guarantee the reliability of the supply chain, they require that manufacturers of medications, packagers, wholesale distributors, and intermediaries involved in the sale or purchase of medications either exchange transaction information that allows them to verify the medications by their lot number, or print a serial number or other unique code on the medications.


To facilitate adherence and monitoring of compliance with standards, the models in UBS’ TJX Series guarantee correct, sharp, permanent coding on glassy surfaces (e.g. those generally used for the production of individual containers, such as vials and ampoules) at high output rates, even if they undergo autoclaving.





Thermal Inkjet printers are specially designed for Inkjet Coding and Marking on primary packaging.


Unlike other technologies, the TJX Series does not require any maintenance. Each cartridge replacement equates to a new printhead.


The TJX Series was devised for direct printing on different substrates, both porous and non-porous, through HP 2.5 cartridge technology in combination with UBS’ range of water-based, solvent-based, and UV LED inks.


Units can reach printing speeds of up to 120 m/min and resolutions of up to 900 dpi.

Related products: